PD Dr. Andreas Kremer



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Effect of Seladelpar on Pruritus in Primary Biliary Cholangitis: 26-Week Analysis of an Ongoing International, randomized, Dose Ranging Phase 2 Study (2018) Kremer A, Bowlus CL, Neff GW, Aspinall R, Galambos MR, Goel A, Hirschfield G, et al. Conference contribution Does the Beneficial Antipruritic Effect of Bezafibrate in Primary Biliary Cholangitis Depend on Autotaxin Activity? (2018) Kremer A, Le Cleac'H A, Wolf K, Chazouilleres O, Lemoinne S, De Chaisemaitin L, Chollet-Martin S, et al. Conference contribution ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro (2018) Schmid R, Wolf K, Robering JW, Strauss S, Strissel P, Strick R, Rübner M, et al. Journal article Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study (2017) Jones D, Boudes PF, Swain MG, Bowlus CL, Galambos MR, Bacon BR, Doerffel Y, et al. Journal article Analysis of shear wave elastography and serum autotaxin as novel non-invasive markers of liver fibrosis in patients with autoimmune hepatitis - a prospective study (2017) Janik MK, Kruk B, Kostrzewa K, Raszeja-Wyszomirska J, Wolf K, Lammert F, Kremer A, et al. Conference contribution Activation of human C-Fibers by Lysophosphatidic Acid (2017) Düll M, Stengel M, Wurm L, Ries V, Kremer A, Namer B Conference contribution Activation of human C-fibres by lysophosphatidic acid (2017) Düll M, Stengel M, Wurm L, Ries V, Kremer A, Namer B Conference contribution norUrsodeoxycholic acid (norUDCA) improves non-alcoholic fatty liver disease (NAFLD): Results from a randomized placebo-controlled, double-blind phase IIa study (2017) Traussnigg S, Schattenberg JM, Demir M, Wiegand J, Geier A, Teuber G, Hofmann WP, et al. Conference contribution Intradermally applied LPA but not bile salts induce itch and pain in humans depending on the mode of application (2017) Kremer A, Düll M, Wurm L, Ries V, Stengel M, Reeh P, Fischer MJM, Namer B Conference contribution LYSOPHOSPHATIDIC ACID INDUCES ITCH AND PAIN IN HUMANS DEPENDING ON THE MODE OF APPLICATION (2017) Düll M, Wurm L, Ries V, Stengel M, Reeh P, Fischer MJ, Namer B, Kremer A Conference contribution